B. Riley Brokers Boost Earnings Estimates for ARWR
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Free Report) – Equities research analysts at B. Riley increased their Q3 2025 earnings estimates for Arrowhead Pharmaceuticals in a research report issued on Tuesday, May 13th. B. Riley analyst M. Mamtani now anticipates that the biotechnology company will post earnings of ($1.24) per share for the quarter, up from […]
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Free Report) – Equities research analysts at B. Riley increased their Q3 2025 earnings estimates for Arrowhead Pharmaceuticals in a research report issued on Tuesday, May 13th. B. Riley analyst M. Mamtani now anticipates that the biotechnology company will post earnings of ($1.24) per share for the quarter, up from […]
